Hyperlipidemia in HIV-infected patients
- 1 April 2003
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 17 (6), 927-929
- https://doi.org/10.1097/00002030-200304110-00023
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Association Between Insulin Resistance and Hepatitis C Virus Chronic Infection in HIV–Hepatitis C Virus–Coinfected Patients Undergoing Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infectionAIDS, 2001
- Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and LipodystrophyClinical Infectious Diseases, 2001
- Fat distribution and metabolic changes in patients with HIV infectionAIDS, 1999
- Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitorsAIDS, 1999
- Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort studyThe Lancet, 1999
- Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapineAIDS, 1999
- Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapyAIDS, 1999
- A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS, 1998
- Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitisArchives of Internal Medicine, 1997